Correction

Published on 21 Jun 2022

Corrigendum: Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer

in Cancer Immunity and Immunotherapy

Shilan Zhu
Jinmiao Lu
Zhibing Lin
Asmaa M. I. Abuzeid
Xiaoyu Chen
Tingting Zhuang
Haiyan Gong
Rongsheng Mi
Yan Huang
Zhaoguo Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.927917

1,295 views
1 citation

Original Research

Published on 20 Jun 2022

Discovering Innate Driver Variants for Risk Assessment of Early Colorectal Cancer Metastasis

in Cancer Immunity and Immunotherapy

Ruo-Fan Ding
Yun Zhang
Lv-Ying Wu
Pan You
Zan-Xi Fang
Zhi-Yuan Li
Zhong-Ying Zhang
Zhi-Liang Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.898117

1,794 views

Review

Published on 20 Jun 2022

Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course

in Cancer Immunity and Immunotherapy

Mengjie Jiang
Yujie Hu
Gang Lin
Chao Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.906251

7,957 views
21 citations

Case Report

Published on 20 Jun 2022

Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report

in Cancer Immunity and Immunotherapy

Xingyun Su
Xinhui Zhou
Cheng Xiao
Wei Peng
Qiangfeng Wang
Yulong Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.750970

1,883 views
1 citation

Review

Published on 17 Jun 2022

Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects

in Cancer Immunity and Immunotherapy

Lukasz Kuryk
Giulia Rodella
Monika Staniszewska
Katarzyna Wanda Pancer
Magdalena Wieczorek
Stefano Salmaso
Paolo Caliceti
Mariangela Garofalo

Frontiers in Oncology

doi 10.3389/fonc.2022.916839

8,354 views
17 citations

Original Research

Published on 16 Jun 2022

Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series

in Cancer Immunity and Immunotherapy

Chuanwei Yang
Yong Cui
Xiaohui Ren
Ming Li
Kefu Yu
Shaoping Shen
Haihui Jiang
Mingxiao Li
Xiaokang Zhang
Xuzhe Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.901797

4,924 views
21 citations

Editorial

Published on 15 Jun 2022

Editorial: Immunologic Mechanisms of Myeloid Neoplasms

in Cancer Immunity and Immunotherapy

Bruno Fattizzo
Matteo Claudio Da Vià
Austin G. Kulasekararaj

Frontiers in Oncology

doi 10.3389/fonc.2022.949633

1,168 views

Original Research

Published on 14 Jun 2022

Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability

in Cancer Immunity and Immunotherapy

Ganjun Yu
Wenying Wang
Xiaobo He
Jia Xu
Rongrong Xu
Tao Wan
Yanfeng Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.895103

4,924 views
9 citations

Original Research

Published on 13 Jun 2022

Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients

in Cancer Immunity and Immunotherapy

Maria Raffaella Petrara
Sarah Shalaby
Elena Ruffoni
Martina Taborelli
Francesco Carmona
Silvia Giunco
Paola Del Bianco
Pierluca Piselli
Diego Serraino
Umberto Cillo

Frontiers in Oncology

doi 10.3389/fonc.2022.899170

2,336 views
2 citations

Original Research

Published on 13 Jun 2022

Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP

in Cancer Immunity and Immunotherapy

Hui Cong
Jian Gao
Qing Wang
Min Du
Huimin Li
Qian Li
Jin Li
Yiyi Liang
Dan Zhao
Hancao Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.872017

3,152 views
3 citations

Review

Published on 10 Jun 2022

Fecal Microbiota Transplantation Effectively Cures a Patient With Severe Bleeding Immune Checkpoint Inhibitor-Associated Colitis and a Short Review

in Cancer Immunity and Immunotherapy

Minmin Chen
Mengyuan Liu
Chenyan Li
Shiqiao Peng
Yiling Li
Xiuying Xu
Mingjun Sun
Xuren Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.913217

3,986 views
16 citations

Original Research

Published on 08 Jun 2022

Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth

in Cancer Immunity and Immunotherapy

Rachel A. Cederberg
Sarah Elizabeth Franks
Brennan J. Wadsworth
Alvina So
Lisa R. Decotret
Michael G. Hall
Rocky Shi
Michael R. Hughes
Kelly M. McNagny
Kevin L. Bennewith

Frontiers in Oncology

doi 10.3389/fonc.2022.841921

3,864 views
9 citations

Original Research

Published on 08 Jun 2022

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas

in Cancer Immunity and Immunotherapy

Qijun Xie
Xianlong Huang
Wu Huang
Fang Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.860640

1,830 views
2 citations

Systematic Review

Published on 06 Jun 2022

Effectiveness and Safety of Therapeutic Vaccines for Precancerous Cervical Lesions: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Shan Cai
Xiaoyu Tan
Ke Miao
Dantong Li
Si Cheng
Pei Li
Xueyang Zeng
Feng Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.918331

4,277 views
7 citations

Original Research

Published on 02 Jun 2022

The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas

in Cancer Immunity and Immunotherapy

Yueyang Ba
Jiahao Su
Shuangqi Gao
Zhi Liao
Zhimin Wu
Chengan Cao
Chaofeng Liang
Jin Gong
Ying Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.899443

2,185 views
2 citations

Original Research

Published on 02 Jun 2022

Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis

in Cancer Immunity and Immunotherapy

Zhou Tian
Baojian Hong
Jianzhong Chen
Zhe Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.891724

3,659 views
8 citations

Navigation group

Articles

Corrigendum: Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer

Discovering Innate Driver Variants for Risk Assessment of Early Colorectal Cancer Metastasis

Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course

Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report

Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects

Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series

Editorial: Immunologic Mechanisms of Myeloid Neoplasms

Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability

Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients

Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP

Fecal Microbiota Transplantation Effectively Cures a Patient With Severe Bleeding Immune Checkpoint Inhibitor-Associated Colitis and a Short Review

Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas

Effectiveness and Safety of Therapeutic Vaccines for Precancerous Cervical Lesions: A Systematic Review and Meta-Analysis

The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas

Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis